Skip to main content

Breadcrumb

  1. Home

Cardiovascular

Valid for Measure Submission

Beta-Blocker Therapy (i.e., Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Succinate) for LVSD Prescribed at Discharge

  • Proportion of heart failure patients age 18 and older with LVSD for whom beta-blocker therapy (i.e., bisoprolol, carvedilol, or sustained-release metoprolol succinate) is prescribed at discharge. For purposes of this measure, LVSD is defined as chart documentation of a left ventricular ejection fraction (LVEF) less than 40% or a narrative description of left ventricular systolic (LVS) function consistent with moderate or severe systolic dysfunction.

    CBE ID
    2438

Bilateral Cardiac Catheterization Rate (IQI 25)

  • Bilateral cardiac catheterization discharges per 1,000 heart catheterizations discharges for coronary artery disease for patients ages 18 years and older. Excludes valid indications for right- side catheterization discharges and obstetric discharges.

    [NOTE: The software provides the rate per hospital discharge. However, common practice reports the measure as per 1,000 discharges. The user must multiply the rate obtained from the software by 1,000 to report specific procedure discharges per 1,000 hospital discharges.]

    CBE ID
    0355

Blood Pressure Screening by 13 Years of Age

  • The percentage of adolescents 13 years of age who had a blood pressure screening with results during the measurement year or the year prior to the measurement year.

    CBE ID
    1552

Blood Pressure Screening by 18 Years of Age

  • The percentage of adolescents 18 years of age who had a blood pressure screening with results during the measurement or the year prior to the measurement year.

    CBE ID
    1553

CAD: Beta-Blocker Treatment after a Heart Attack

  • Percentage of patients who have a claim indicating beta blocker therapy or who received an ambulatory prescription for beta-blockers rendered within 7 days after discharge.

    CBE ID
    0072

Cardiac Imaging for Preoperative Risk Assessment for Non-Cardiac, Low-Risk Surgery

  • This measure calculates the percentage of stress echocardiography, single photon emission computed tomography myocardial perfusion imaging (SPECT MPI), stress magnetic resonance imaging (MRI), or computed coronary tomography angiography (CCTA) performed at each facility in the 30 days prior to an ambulatory non-cardiac, low-risk surgery performed at any location. The measure is calculated based on a one-year window of Medicare claims data.

    CBE ID
    0669

Cardiovascular

The Cardiovascular Standing Committee  oversees the consensus based entity's portfolio of Cardiovascular measures, which includes measures for acute myocardial infarction, percutaneous coronary intervention, ischemic vascular disease, heart failure, hypertension, rhythm disorders, and valvular heart disease.